Comment on Neumann et al. 'Differential antiviral effect of PEG-interferon-alpha-2b on HIV and HCV in the treatment of HIV/HCV co-infected patients'

MeSH terms

• Administration, Oral
• Antiretroviral Therapy, Highly Active
• Antiviral Agents / administration & dosage
• Antiviral Agents / therapeutic use*
• HIV Infections / complications*
• HIV Infections / drug therapy*
• HIV* / physiology
• Hepatitis C / complications*
• Hepatitis C / drug therapy*
• Humans
• Injections, Subcutaneous
• Interferon alpha-2
• Interferon-alpha / administration & dosage
• Interferon-alpha / therapeutic use*
• Polyethylene Glycols
• Recombinant Proteins
• Ribavirin / administration & dosage
• Ribavirin / therapeutic use
• Viral Load
• Virus Replication